Steward Partners Investment Advisory, LLC Biotechnology

Steward Partners Investment Advisory, LLC

$12.3 Billion
Q2 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
VRTX Vertex Pharmaceuticals Inc	$99.5B	$18.5 Million 0.15% of portfolio	41,551	Q2 2025 Added 1.26%
NVO Novo Nordisk A S	$112B	$9.54 Million 0.08% of portfolio	138,214	Q2 2025 Added 86.19%
VKTX Viking Therapeutics, Inc.	$3.06B	$7.17 Million 0.06% of portfolio	270,409	Q2 2025 Added 13.6%
APLS Apellis Pharmaceuticals, Inc.	$2.63B	$2.44 Million 0.02% of portfolio	140,975	Q2 2025 Added 15.39%
REGN Regeneron Pharmaceuticals, Inc.	$59.7B	$2.25 Million 0.02% of portfolio	4,286	Q2 2025 Reduced 20.16%
CRMD Cor Medix Inc.	$474M	$2.04 Million 0.02% of portfolio	165,562	Q2 2025 Added 3.71%
ALT Altimmune, Inc.	$177M	$825,000 0.01% of portfolio	213,384	Q2 2025 Added 43.01%
CORT Corcept Therapeutics Inc	$7.88B	$742,000 0.01% of portfolio	10,121	Q2 2025 Reduced 8.92%
RNA Avidity Biosciences, Inc.	$2.41B	$629,000 0.01% of portfolio	22,183	Q2 2025 Reduced 52.55%
ALNY Alnylam Pharmaceuticals, Inc.	$52.9B	$442,000 0.0% of portfolio	1,357	Q2 2025 Added 27.78%
EXEL Exelixis, Inc.	$12.1B	$422,000 0.0% of portfolio	9,586	Q2 2025 Reduced 15.46%
BPMC Blueprint Medicines Corp	$7.73B	$327,000 0.0% of portfolio	2,552	Q2 2025 Reduced 2.22%
SMMT Summit Therapeutics Inc.	$5.17B	$265,000 0.0% of portfolio	12,466	Q2 2025 Added 56.29%
RXRX Recursion Pharmaceuticals, Inc.	$976M	$257,000 0.0% of portfolio	50,865	Q1 2025 Added 249.23%
ETNB 89bio, Inc.	$420M	$251,000 0.0% of portfolio	25,567	Q2 2025 Added 23.16%
RPRX Royalty Pharma PLC	$15.7B	$242,000 0.0% of portfolio	6,728	Q2 2025 Reduced 12.19%
UTHR United Therapeutics Corp	$13.7B	$228,000 0.0% of portfolio	794	Q2 2025 Reduced 25.45%
ETON Eton Pharmaceuticals, Inc.	$438M	$200,000 0.0% of portfolio	14,064	Q2 2025 Added 87.55%
ARGX Argenx Se	$35.3B	$196,000 0.0% of portfolio	357	Q2 2025 Reduced 4.03%
BGNE Bei Gene, Ltd.	$23.5B	$158,000 0.0% of portfolio	699	Q2 2025 Reduced 1.13%
MIRM Mirum Pharmaceuticals, Inc.	$2.38B	$154,000 0.0% of portfolio	3,031	Q2 2025 Added 47.85%
BMRN Biomarin Pharmaceutical Inc	$10.6B	$115,000 0.0% of portfolio	2,096	Q2 2025 Added 50.14%
IMMP Immutep LTD	$147M	$100,000 0.0% of portfolio	61,000	Q1 2025 New
CRSP Crispr Therapeutics Ag	$4.42B	$96,000 0.0% of portfolio	1,992	Q2 2025 Added 38.33%
TECH Bio Techne Corp	$2.07B	$93,000 0.0% of portfolio	1,811	Q2 2025 Added 0.56%
LQDA Liquidia Corp	$1.55B	$77,000 0.0% of portfolio	6,200	Q2 2025 Added 24.0%
MRNA Moderna, Inc.	$10B	$74,000 0.0% of portfolio	2,707	Q2 2025 Added 3.52%
TRVI Trevi Therapeutics, Inc.	$428M	$65,000 0.0% of portfolio	12,000	Q2 2025 Added 20.0%
RARE Ultragenyx Pharmaceutical Inc.	$1.97B	$62,000 0.0% of portfolio	1,710	Q4 2024 Added 2.09%
INSM Insmed Inc	$16.5B	$61,000 0.0% of portfolio	614	Q2 2025 Reduced 18.46%
INCY Incyte Corp	$18.2B	$56,000 0.0% of portfolio	827	Q2 2025 Added 1.85%
BBIO Bridge Bio Pharma, Inc.	$7.28B	$53,000 0.0% of portfolio	1,250	Q2 2025 Added 22.31%
IONS Ionis Pharmaceuticals Inc	$5.85B	$48,000 0.0% of portfolio	1,221	Q2 2025 Added 12.02%
MNKD Mannkind Corp	$942M	$47,000 0.0% of portfolio	12,627	Q4 2024 Reduced 53.97%
RGNX Regenxbio Inc.	$350M	$46,000 0.0% of portfolio	5,663	Q2 2025 Added 754.15%
ARDX Ardelyx, Inc.	$866M	$38,000 0.0% of portfolio	9,728	Q1 2024 Added 462.96%
RCKT Rocket Pharmaceuticals, Inc.	$220M	$33,000 0.0% of portfolio	13,840	Q2 2025 Added 22.05%
ADMA Adma Biologics, Inc.	$3.29B	$32,000 0.0% of portfolio	1,812	Q2 2025 Reduced 34.11%
BNTX Bio N Tech Se	$26.9B	$32,000 0.0% of portfolio	307	Q2 2025 Added 11.64%
IBRX Immunity Bio, Inc.	$989M	$21,000 0.0% of portfolio	8,276	Q2 2025 Added 56.86%
RLAY Relay Therapeutics, Inc.	$403M	$21,000 0.0% of portfolio	6,100	Q1 2025 Reduced 6.15%
LXRX Lexicon Pharmaceuticals, Inc.	$200M	$20,000 0.0% of portfolio	21,423	Q2 2025 Added 0.47%
ORMP Oramed Pharmaceuticals Inc.	$81.5M	$19,000 0.0% of portfolio	8,826	Q1 2024 New
IOVA Iovance Biotherapeutics, Inc.	$352M	$18,000 0.0% of portfolio	10,497	Q2 2025 Reduced 0.78%
TBPH Theravance Biopharma, Inc.	$796M	$16,000 0.0% of portfolio	1,500	Q1 2024 New
CPRX Catalyst Pharmaceuticals, Inc.	$2.09B	$15,000 0.0% of portfolio	734	Q2 2025 Reduced 98.32%
ACAD Acadia Pharmaceuticals Inc	$4.12B	$13,000 0.0% of portfolio	649	Q4 2024 Added 44.22%
AMLX Amylyx Pharmaceuticals, Inc.	$481M	$12,000 0.0% of portfolio	2,000	Q4 2023 Reduced 9.09%
ABUS Arbutus Biopharma Corp	$510M	$12,000 0.0% of portfolio	4,000	Q4 2022 Reduced 20.0%
DYN Dyne Therapeutics, Inc.	$602M	$12,000 0.0% of portfolio	1,350	Q2 2025 New

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Steward Partners Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Steward Partners Investment Advisory, LLC with notifications on news.